The Medicines (Pharmacy and General Sale—Exemption) Amendment Order 2005

Amendment of Schedule 1 to the principal Order

3.  In Schedule 1 to the principal Order (exemptions for certain purposes from the provisions of sections 52 and 53 of the Medicines Act)—

(a) in Part I, in paragraph 2—

(i) in the entry in column 2, in paragraph (b)—

(aa) omit “Atrophine sulphate,”, “Bethanecol chloride”, and “Carbachol,”;

(bb) after “Cyclopentolate hydrochloride,” insert “Fusidic acid,”; and

(cc) omit “Homatrophine hydrobromide,”, “Hyoscine hydrobromide,”, “Naphazoline hydrochloride,”, “Naphazoline nitrate,”, “Neostigmine methylsulphate,”, “Physostigmine methylsulphate,”, “Physostigmine salicylate,”, “Physostigmine sulphate,”, “Pilocarpine hydrochloride,” and “Pilocarpine nitrate.”;

(ii) for the entry in column 3, substitute the following entry—

“2.   The sale or supply shall be only (a) in the case of medicinal products on a general sale list and pharmacy medicines, in the course of their professional practice; (b) in the case of prescription only medicines, in the course of their professional practice and in an emergency.”;

(b) insert, at the end of Part II, the following paragraph—

“14.

A prison officer.

All medicinal products on a general sale list.

The supply shall only be so far as is necessary for the treatment of prisoners.”.